24 Days Left to Join
Sign Up for Lotrimin and Tinactin Class Action Lawsuit
Lotrimin and Tinactin class action lawsuit is currently open:
Those who meet eligibility criteria should apply before the deadline March 9, 2026. Lawsuit claims recalled Lotrimin® and Tinactin® sprays were contaminated with benzene and sold without proper disclosure to consumers.
Open Class Actions > Lotrimin and Tinactin Class Action
Lotrimin and Tinactin Class Action Lawsuit
A class action lawsuit has been filed against Bayer and other defendants due to allegations that certain Lotrimin® and Tinactin® antifungal spray products (recalled in October 2021) contained benzene and were sold without adequate disclosure. This Bayer Antifungals (Lotrimin and Tinaction) class action case is Huertas et al. v. Aeropres Corp., et al., Case No. 2:21-cv-20021-SRC-CF, in the U.S. District Court for the District of New Jersey.
The named plaintiffs (Settlement Class Representatives) include Juan Huertas, Eva Mistretta, Mike Poovey, Darrell Stewart, and Jeremy Wyant. The Bayer Antifungals (Lotrimin and Tinaction) lawsuit details include legal claims such as breach of express/implied warranties, fraud, unjust enrichment, negligent misrepresentation, and state consumer-protection claims.
The case began in 2021 (based on the filing year in the docket number) and reached a settlement after a September 5, 2025 mediation, with the settlement agreement executed December 8, 2025. Settlement Class Counsel includes attorneys from Silver Golub & Teitell LLP, Bursor & Fisher, P.A., and Faruqi & Faruqi, LLP.
The named plaintiffs (Settlement Class Representatives) include Juan Huertas, Eva Mistretta, Mike Poovey, Darrell Stewart, and Jeremy Wyant. The Bayer Antifungals (Lotrimin and Tinaction) lawsuit details include legal claims such as breach of express/implied warranties, fraud, unjust enrichment, negligent misrepresentation, and state consumer-protection claims.
The case began in 2021 (based on the filing year in the docket number) and reached a settlement after a September 5, 2025 mediation, with the settlement agreement executed December 8, 2025. Settlement Class Counsel includes attorneys from Silver Golub & Teitell LLP, Bursor & Fisher, P.A., and Faruqi & Faruqi, LLP.
Lawsuit Name
Huertas et al. v. Aeropres Corp., et al.
Court
United States District Court for the District of New Jersey
Case Number
2:21-cv-20021-SRC-CF
Judge
Hon. Stanley R. Chesler and Hon. Cari Fais
Plaintiffs
Juan Huertas, Eva Mistretta, Jeremy Wyant, Mike Poovey, Darrell Stewart
Defendants
Aeropres Corporation; Aux Sable Liquid Products LP; Bayer HealthCare LLC; Bayer U.S. LLC; Beiersdorf Manufacturing, LLC; Beiersdorf, Inc.; Beiersdorf North America, Inc.; BP Energy Company
Key Allegation
Recalled Lotrimin/Tinactin antifungal sprays allegedly contained benzene and were sold without adequate disclosure.
Lotrimin and Tinactin Class Action Settlement - $4,850,000
The latest Bayer Antifungals (Lotrimin and Tinaction) settlement update confirms a $4,850,000 non-reversionary cash fund resolving claims that certain recalled Lotrimin® and Tinactin® spray products contained benzene and were sold without adequate disclosure. The Bayer Antifungals (Lotrimin and Tinaction) lawsuit settlement amount will be used to pay valid claims, attorneys’ fees, notice, and administration costs.
The settlement amount was negotiated after arm’s-length mediation before retired U.S. Magistrate Judge Diane M. Welsh and reflects the parties’ assessment of litigation risk, potential nationwide consumer fraud exposure, recall participation offsets, and the costs of continued trial and appeal.
Under the settlement, consumers who purchased covered antifungal spray products beginning November 16, 2015 may qualify. Bayer Antifungals (Lotrimin and Tinaction) settlement eligibility includes U.S. purchasers of specific recalled aerosol sprays distributed between September 2018 and September 2021. In addition to funding payments and administration, the company must provide nationwide notice and settlement administration oversight.
The settlement amount was negotiated after arm’s-length mediation before retired U.S. Magistrate Judge Diane M. Welsh and reflects the parties’ assessment of litigation risk, potential nationwide consumer fraud exposure, recall participation offsets, and the costs of continued trial and appeal.
Under the settlement, consumers who purchased covered antifungal spray products beginning November 16, 2015 may qualify. Bayer Antifungals (Lotrimin and Tinaction) settlement eligibility includes U.S. purchasers of specific recalled aerosol sprays distributed between September 2018 and September 2021. In addition to funding payments and administration, the company must provide nationwide notice and settlement administration oversight.
Deadline for filing a claim: March 9, 2026
Antifungal Creams Lotrimin and Tinactin Class Action Payout: 21
If you’re asking, how much will I get from Bayer Antifungals (Lotrimin and Tinaction) lawsuit, the answer depends on proof and claim volume. The Bayer Antifungals (Lotrimin and Tinaction) settlement amount per person is:
- With proof of purchase: Refund of the full purchase price (excluding tax) per eligible product
- Without proof: $7 per product, capped at 3 products per household
The $7 figure reflects an estimated average retail price range for aerosol antifungal sprays and represents a negotiated compromise value without requiring receipts. The 3-product cap limits fraud risk and preserves the $4,850,000 settlement fund for verified purchasers while still allowing recovery for consumers without receipts.
The Bayer Antifungals (Lotrimin and Tinaction) settlement payout date follows final court approval (hearing set for May 13, 2026) and resolution of any appeals. Payments begin after the settlement becomes final and claims are validated.
- With proof of purchase: Refund of the full purchase price (excluding tax) per eligible product
- Without proof: $7 per product, capped at 3 products per household
The $7 figure reflects an estimated average retail price range for aerosol antifungal sprays and represents a negotiated compromise value without requiring receipts. The 3-product cap limits fraud risk and preserves the $4,850,000 settlement fund for verified purchasers while still allowing recovery for consumers without receipts.
The Bayer Antifungals (Lotrimin and Tinaction) settlement payout date follows final court approval (hearing set for May 13, 2026) and resolution of any appeals. Payments begin after the settlement becomes final and claims are validated.
Antifungal Creams Lotrimin and Tinactin Class Action Eligibility
This settlement applies to anyone in the United States who purchased a Bayer Product beginning no earlier than November 16, 2015. A “Bayer Product” is a Lotrimin and Tinactin spray products listed below used to treat athlete’s foot, ringworm, and other fungal infections that were subject to Bayer’s October 2021 recall (specifically, all Lotrimin and Tinactin spray products with lot numbers beginning with TN, CV, or NAA, distributed between September 2018 and September 2021):
• Lotrimin® Anti-Fungal (AF) Athlete’s Foot Powder Spray
• Lotrimin® Anti-Fungal Jock Itch (AFJI) Athlete’s Foot Powder Spray
• Lotrimin® Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray
• Lotrimin® AF Athlete’s Foot Liquid Spray
• Lotrimin® AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
• Tinactin® Jock Itch (JI) Powder Spray
• Tinactin® Athlete’s Foot Deodorant Powder Spray
• Tinactin® Athlete’s Foot Powder Spray
• Tinactin® Athlete’s Foot Liquid Spray
To make a Proof-of-Purchase Claim, you must provide a receipt clearly reflecting 1) the purchase date, 2) the specific Bayer product purchased, and 3) the price of the product. The purchase date must reflect that you purchased a product covered by Bayer’s October 2021 recall (which includes products purchased from September 2018 to October 2021). A barcode or photograph of the product is not sufficient proof of purchase.
• Lotrimin® Anti-Fungal (AF) Athlete’s Foot Powder Spray
• Lotrimin® Anti-Fungal Jock Itch (AFJI) Athlete’s Foot Powder Spray
• Lotrimin® Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray
• Lotrimin® AF Athlete’s Foot Liquid Spray
• Lotrimin® AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
• Tinactin® Jock Itch (JI) Powder Spray
• Tinactin® Athlete’s Foot Deodorant Powder Spray
• Tinactin® Athlete’s Foot Powder Spray
• Tinactin® Athlete’s Foot Liquid Spray
To make a Proof-of-Purchase Claim, you must provide a receipt clearly reflecting 1) the purchase date, 2) the specific Bayer product purchased, and 3) the price of the product. The purchase date must reflect that you purchased a product covered by Bayer’s October 2021 recall (which includes products purchased from September 2018 to October 2021). A barcode or photograph of the product is not sufficient proof of purchase.
Purchased a Lotrimin or Tinactin product after November 15, 2015
The antifungal was subject to Bayer's October 2021 recall
Antifungal Creams Lotrimin and Tinactin Class Action Claim Form
The Antifungal Creams Lotrimin and Tinactin class action claim form is quick and simple with Chimo. Some settlements take longer due to court approval, appeals, or fraud checks, but Chimo streamlines the process so you can get your share fas. Here's how to file a claim against Antifungal Creams Lotrimin and Tinactin:
1
Check eligibility now by answering a few quick questions
2
Tell us where you want your check sent
3
Submit your form before March 9, 2026
You'll receive confirmation and updates on your claim status.
FAQ
Benzene contamination was allegedly linked to aerosol propellants used in spray products. The lawsuit claims products were sold without adequate disclosure of this risk.
Yes. Certain Lotrimin® and Tinactin® aerosol sprays were recalled in October 2021 after testing detected benzene in specific lots.
No. This settlement focuses on purchase-based claims, not personal injury. You only need to show (or certify) that you purchased eligible products.
The case targets specific recalled spray products, not creams or powders. Only listed aerosol products are covered.
If you received compensation through Bayer’s recall program, your settlement payout may be reduced or limited to avoid duplicate recovery.
This prevents duplicate submissions from the same address and helps preserve the $4.85M fund for legitimate claimants.
CHIMO
Class Actions
Unclaimed Property
Sign up for updates on new lawsuits
and unclaimed money opportunities
© 2025 Chimo - All rights reserved.